Insider trades
Thane Wettig, CEO of Kyntra Bio KYNB, has filed 5 purchases and 9 sales on the open market. Over the past 12 months that comes to a net purchase of $53.6K. The latest trade was on 06/06.
Thane Wettig
CEO
- Company
- Kyntra Bio KYNB
- First filing
- 23/02/23
- Trades
- 51 trades
- Buys / sales
- 5 / 9
- 12-month net buying
- $53.6K
- Last trade
- 06/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Kyntra BioKYNB | Open-market buyAmendment | 05/14 | 05/19 | 2,800 sh | $7.09 | $19,852 | +11.5% |
Kyntra BioKYNB | Open-market buy | 05/14 | 05/18 | 2,800 sh | $7.09 | $19,852 | −9.3% |
KYNB | Open-market buy | 25/11/13–25/11/17 | 25/11/17 | 3,700 sh2 trades | $9.12avg. | $33,750 | +17.4% |
Kyntra BioKYNB | Open-market buy | 25/03/24 | 25/03/25 | 145,000 sh | $0.35 | $50,750 | +36.4% |
Kyntra BioKYNB | Open-market buy | 24/03/07 | 24/03/11 | 50,000 sh | $1.91 | $95,500 | +11.9% |
Kyntra BioKYNB | Open-market sale | 23/06/23 | 23/06/26 | 791 sh | $16.53 | $13,075.23 | −0.7% |
KYNB | Open-market saleAmendment | 23/06/07 | 23/06/22 | 1,758 sh2 trades | $17.04avg. | $29,956.32 | −1.6% |
KYNB | Open-market sale | 23/06/07 | 23/06/09 | 1,758 sh2 trades | $17.04avg. | $29,956.32 | −1.6% |
Kyntra BioKYNB | Open-market sale | 23/03/23 | 23/03/24 | 905 sh | $18.71 | $16,932.55 | −0.8% |
KYNB | Open-market sale | 23/03/08–23/03/10 | 23/03/10 | 13,934 sh3 trades | $20.63avg. | $287,481.2 | −11.1% |